-
Registration & networkingBusiness Centre: Lower Ground Floor30 mins
- Investment Summit
Registration
-
Pau Casals5 mins
- Investment Summit
Speakers
)
-
Pau Casals45 mins
- Investment Summit
Bringing together investors across the funding spectrum (from seed-stage VCs to growth investors) to share what drives decision making in today’s market
)
)
)
-
Pau Casals40 mins
- Investment Summit
The gaps biotech startups face beyond just funding Followed by investor reflections – how they can better support startups beyond capital
)
)
)
)
)
-
Pau Casals35 mins
- Investment Summit
A candid conversation between a biotech founder and their early investor exploring the startup journey
)
)
-
Refreshment & networking breakPau Casals25 mins
- Investment Summit
1-2-1 Meetings
-
Pau Casals30 mins
- Investment Summit
Pioneering investment model: Explore how Europe’s first dedicated fund for children's health was originally conceived, addressing a long-standing funding gap in innovation for children’s medicines, te ...
)
-
Pau Casals40 mins
- Investment Summit
A rapid-fire panel / multi-perspective session on high-growth areas in biotech.
Chairperson
)
)
)
-
Pau Casals5 mins
- Investment Summit
Wrap up from senior VC – covering the landscape of what’s next and where biotech investment will grow for the next 5 years
-
Investment Summit & Women In Advanced Therapies LunchPau Casals60 mins
- Investment Summit
- Women in Advanced Therapies
Lunch break and networking
-
Pau Casals5 mins
- Women in Advanced Therapies
Welcome address
)
-
Pau Casals40 mins
- Women in Advanced Therapies
Explore the complex mix of visible and invisible barriers that shape entry into the industry. Address systemic challenges and how we can create a truly inclusive workforceChairperson
)
)
)
)
-
Networking breakPau Casals20 mins
- Women in Advanced Therapies
1-2-1 Meetings
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
-
Pau Casals45 mins
- Women in Advanced Therapies
)
)
)
)
)
)
)
-
Refreshment & networking breakPau Casals20 mins
- Women in Advanced Therapies
1-2-1 Meetings
-
Pau Casals50 mins
- Women in Advanced Therapies
Following on from the earlier roundtables, the moderator from each table will share the key points from the discussion. Enabling audience members to receive insights across all topics and encouraging further discussion post-event.
-
Pau Casals20 mins
- Women in Advanced Therapies
-
Building resilience and strategy crucial for long term success
-
Navigating uncertainty and leading with confidence
-
Owning your leadership style and being a successful leader
-
Pau Casals5 mins
- Women in Advanced Therapies
Closing address
-
Infinity Pool90 mins
- Networking
Join us for an unforgettable evening overlooking the marina at the iconic Hotel Arts Barcelona. Connect with fellow attendees – expect great impressive views, great conversation, and a few surprises a ...
-
Hotel Arts Lobby60 mins
- Networking
Begin your day with an energising run along Barcelona’s waterfront. Join fellow delegates for a casual 5k starting from the Hotel Arts lobby, blending light exercise, fresh sea air, and plenty of info ...
-
Exhibition Hall90 mins
- Networking
-
Partnering room located in the Pau Casals Ballroom60 mins
- Workshop
Scaling for ATMP commercialisationSponsored by
-
Plenary10 mins
- Plenary
)
-
Plenary45 mins
- Plenary
This session will explore the current state of the CGT industry, with a focus on Europe’s evolving role amid global shifts. In a climate where research ecosystems face mounting uncertainty — particularly following moves in the U.S. to scale back federal support for scientific innovation, Europe must sharpen its competitiveness to secure its leadership in advanced therapies. We will examine emerging trends, key market dynamics, and the urgent need for Europe to overcome challenges around scalability, affordability, and patient access. The discussion will highlight how external pressures are reshaping Europe’s strategic priorities — and what actions are needed now to turn today’s challenges into tomorrow’s leadership in CGT.
)
)
)
-
Plenary35 mins
- Plenary
Deep dive into the regulatory framework that governs CGT across major rejoins, focusing on recent updates, new legislation and how companies can navigate the changing landscape.
)
)
)
-
Coffee and networking breakExhibition Hall30 mins
- Networking
-
Theatre 135 mins
- R&D, clinical innovation & translation
- Cutting edge developments in CRISPR, gene editing and cell engineering
- The next wave of in vivo and ex vivo gene therapies
- What breakthroughs are expected to reshape the industry?
Sponsored by
-
Theatre 235 mins
- Manufacturing, scale up & commercial strategy
-
As the pressure mounts to deliver advanced therapies faster, cheaper, and closer to the patient, decentralised manufacturing is stepping into the spotlight. But does breaking away from centralised models really deliver on cost?
-
This panel dives into the economic realities behind the decentralisation trend. Are localised manufacturing hubs the answer to cutting costs, or do they introduce new layers of complexity and hidden spend? From infrastructure investments to regulatory headaches, we’ll separate financial fact from fiction and explore whether decentralisation is a bold leap forward or an expensive detour.
Sponsored by
Chairperson -
Partnering room located in the Pau Casals Ballroom35 mins
- Workshop
Showcase how Nordic countries are combining national strengths in biomanufacturing, data infrastructure, and public-private partnerships to build a regional ATMP hub.
)
)
)
)
)
)
)
)
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
Sponsored by
)
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
Current key barriers impeding progress toward first-in-human trials in cell therapies, as well as highlights on strategies - from discovery through CMC development - to overcome these challenges with ... -
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
)
-
Theatre 140 mins
- R&D, clinical innovation & translation
-
Why characterisation and analytics remain a major hurdle.
-
Collaborative approaches to tackling technical challenges
-
Best practices and emerging solutions.
-
Theatre 240 mins
- Manufacturing, scale up & commercial strategy
- Balancing technical and financial realities in manufacturing
- When to invest in infrastructure vs outsourcing
- The role of automation in optimising CMC process
Chairperson -
Partnering room located in the Pau Casals Ballroom40 mins
- Workshop
Highlight how the UK is strengthening its ATMP ecosystem through coordinated infrastructure, regulatory agility, and health system integration — with a forward-looking, opportunity-driven lens.
)
)
)
)
)
)
)
)
-
Partnering room located in the Pau Casals Ballroom60 mins
- Workshop
Lunch providedSponsored by
)
)
-
Lunch & networking breakExhibition Hall60 mins
- Networking
1-2-1 meetings
-
Theatre 140 mins
- R&D, clinical innovation & translation
-
How startups secure investment before reaching human trials
-
strategic and tactical guidance on how to secure the right funding at the right time, from seed rounds through Series A
-
Investor insights into due diligence, risk mitigation and valuation and what good really looks like
Chairperson -
Theatre 240 mins
- Manufacturing, scale up & commercial strategy
-
Transitioning from academic proof of concept to first-in-human
-
Why biotech teams must integrate CMC, regulatory and pharmacology early
-
Avoiding pitfalls of overselling and overpromising
Sponsored by
-
Picasso Meeting Room60 mins
- Workshop
Invite only
Model – leave your company affiliation at the door. This is a non-competitive, bias-free space – if you want to wax lyrical about your capabilities or tech, do it in the hallway (or in the ATE agenda!). This is a open-collaborative space and we want participants to have an equal footing and contribution to challenges and eventual solutions.
Topics:
- Where are the sticking points for decentralised manufacturing
o Why “Regionalised” as a model over PoC or Centralised
o What are the sticking points for QC/Analytics and regulatory
- What solutions are working and why?
o Case studies of successful implementation (HTAs, Galapagos/BCA)
o What role do vendors play in this radically different landscape, and what disruptive technologies support progress
- How can the industry collaborate better?
o Where is pre-competitive collaboration most valuable
o What approaches will support acceleration
o What barriers do we need to address through the decentralized working group
)
)
)
)
)
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
Sponsored by
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
Cell therapies through their curative potential offer life-changing treatment options to patients with no other recourse. In a few short years, they have achieved unprecedented success as evidenced by ...Sponsored by
)
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
Sponsored by
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
)
)
-
Coffee break & networkingExhibition Hall20 mins
- Networking
1-2-1 Meetings
-
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
IP and exclusivity strategies for navigating CGT innovations from conception to commercializationSponsored by
-
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
From Bench to Bedside Successfully: ATMPs commercial strategy long before Phase III -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Gene therapy communication strategy: Bridging development, approval and stakeholder engagement beyond KOLs -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Digital Infrastructure & Data Harmonisation: Enablers for CGT Access & Scale -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Funding strategies for early-stage cell and gene therapy companies -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Academic Innovation vs Industry Expectations: How to translate your Preclinical Data -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Building the right team – who should be involved at each development stage?Chairperson -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Overcoming the barriers to scale-up in cell therapy manufacturingChairperson -
Partnering room located in the Pau Casals Ballroom60 mins
- Roundtable
Promises and challenges of current in vivo CAR-T therapy approachesChairperson -
Theatre 155 mins
- Workshop
Explore Spain’s growing potential as a strategic ATMP manufacturing and clinical trial hub within the EU.Speakers
)
)
)
)
)
-
Networking Happy HourExhibition Hall105 mins
- Networking
-
Partnering room located in the Pau Casals Ballroom60 mins
- Workshop
Adeno-associated virus (AAV) remains the predominant viral vector in gene therapy, with recent funding trends favoring de-risked programs supported by strong clinical data and commercial viability.Sponsored by
Chairperson
)
)
-
Plenary5 mins
- Plenary
Welcome remarks day 2
-
Plenary70 mins
- Plenary
Join us for an exciting session where innovative biotech start-ups pitch their groundbreaking ideas and solutions. Watch as they present to a panel of expert investors, who will provide real-time feedback, insights, and guidance. This is a unique opportunity to explore cutting-edge advancements in the biotech space and gain valuable perspectives from both entrepreneurs and industry leaders.Sponsored by
Chairperson -
Picasso Meeting Room70 mins
- Workshop
Invite only
Model – leave your company affiliation at the door. This is a non-competitive, bias-free space – if you want to wax lyrical about your capabilities or tech, do it in the hallway (or in the ATE agenda!). This is a open-collaborative space and we want participants to have an equal footing and contribution to challenges and eventual solutions.
Session overview:
- Welcome and framing from moderators/advisory committee, framing key automation challenges (labor dependency, reproducibility, tech transfer)
- Introductions (Name, org, and interest in automation)
- Facilitated roundtable with 2-3 breakout themes to guide the discussion
)
)
)
)
)
)
)
-
Plenary45 mins
- Plenary
Today's CGT startups are facing the toughest fundraising environment in years — and solid science alone isn’t enough. This panel digs into the hard truths: How the market squeeze is reshaping funding dynamics, why traditional playbooks aren't working, and what it takes to stand out when investors are more selective than ever. Real stories. Real setbacks. Real strategies for surviving and scaling in a high-stakes market.
)
)
)
-
Networking & coffee breakExhibition Hall30 mins
- Networking
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
-
Partnering room45 mins
- Workshop
A closed-door, outcome-driven discussion aligning top industry leaders around immediate actions to implement ARM’s EU Policy Blueprint and unlock scalable patient access across Europe.
)
)
)
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
-
Theatre 215 mins
- R&D, clinical innovation & translation
)
-
Theatre 115 mins
- R&D, clinical innovation & translation
Chairperson -
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
)
)
-
Theatre 115 mins
- Manufacturing, scale up & commercial strategy
-
Theatre 215 mins
- Manufacturing, scale up & commercial strategy
Effective IP strategy for C>s presents unique challenges compared to traditional pharmaceuticals and biologics. To secure robust IP that protects the market and attracts investors, companies need to ...Sponsored by
)
-
Theatre 130 mins
- R&D, clinical innovation & translation
-
Best practices for early interactions with EMA, FDA, etc.
-
How proactive regulatory engagement reduces delays and de-risk trials
-
Lessons learned from companies that successfully navigated approval
Sponsored by
ChairpersonSpeakers -
Theatre 230 mins
- Manufacturing, scale up & commercial strategy
-
Explore strategies for securing reimbursement and market access for cell and gene therapies, focusing on pricing, HTAs, and policy advocacy to ensure patient access.
)
)
)
)
)
)
-
Partnering room located in the Pau Casals Ballroom75 mins
- Workshop
Lunch provided
A Case Study and Panel Discussion featuring ADVA X3 from Adva Biotechnology, and Autolomate from Autolomous
Sponsored by
)
)
-
Lunch breakExhibition Hall60 mins
- Networking
1-2-1 meetings
-
Plenary10 mins
- Plenary
Sponsored by
-
Plenary35 mins
- Plenary
AI is everywhere, but in CGT, real deployment remains limited. This session goes beyond the buzz to explore the tangible opportunities, early wins, and critical barriers to broader adoption. We’ll loo ...
)
)
-
Plenary35 mins
- Plenary
As we wrap up two days of deep discussions on the current state of the European CGT landscape, this final panel will chart the path ahead. Which steps must Europe take to remain competitive and lead the way in the next 5–10 years? Each panellist will share their key takeaways from the last two days, reflecting on the insights, challenges, and opportunities discussed.Chairperson
)
)
-
Plenary5 mins
- Plenary